TrialBMC neurology2013

Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study.

Victor M Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.